Dr. Gerald Dorros - Founder
Dr. Gerald Dorros is a founding member of San Francisco Science. He also serves as Director to several of its portfolio companies.
Dr. Dorros is world renowned for his leadership in the field of interventional cardiology and peripheral vascular disease diagnosis. He joined the Arizona Heart Institute Foundation, Phoenix, Arizona, in
1997 and served as its President. He is the Medical Director of the William Dorros-Isadore Feuer Interventional Cardiovascular Disease Foundation in Scottsdale, Arizona, and Milwaukee, Wisconsin.
In 1978, he was the third U.S. physician to perform coronary angioplasty. His research has involved
critical limb ischemia, limb salvage, atherectomy, aortic and mitral valvuloplasty, carotid angioplasty, treatment of diffusely diseased coronary vein grafts, coronary angioplasty of high risk inoperable surgical patients, and endovascular aortic aneurysm repair of high risk surgical patients.
Dr. Dorros received an AB from Dartmouth College, Hanover, New Hampshire and a medical degree from Albert Einstein College of Medicine of Yeshiva University, Bronx, NY. Throughout his 29 years in medicine, Dr. Dorros has held multiple faculty appointments including Harvard Medical School (1971-72), Boston University School of Medicine (1972-77), Medical College of Wisconsin (1980 to present) and the University of Wisconsin Medical School (1978-80 and 1991-94). He was a founding member of the National Heart, Lung and Blood Institute's PTCA Registry, and was principal author of the first
manuscript detailing the complications associated with PTCA.
Dr. Dorros' credentials have enabled him to operate and teach in the U.S. and ten other countries. He is a fellow of many scientific societies, on the editorial board for numerous medical journals, and has been a medical advisor to numerous companies. He has authored hundreds of journal articles and has been an invited lecturer and live case demonstrator at meetings and Congresses throughout the world. He was a co-founder of Arterial Vascular Engineering, Inc., a leading coronary stent company acquired out of
public ownership in 1999 by Medtronic Inc.
Back to Management Page
|
|
